Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Data mining sources
1.3.1 Zonal/Country
1.4 Base estimates and calculations
1.4.1 Base year calculation
1.4.2 Key trends for market estimation
1.5 Primary research and validation
1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
2.2 Key market trends
2.2.1 Zonal trends
2.2.2 Ownership trends
2.2.3 Surgery type trends
2.2.4 Specialty type trends
2.2.5 Service trends
2.3 CXO perspectives: Strategic imperatives
2.3.1 Key decision points for industry executives
2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Rise in number of surgical procedures
3.2.1.3 Favorable reimbursements and government policies
3.2.1.4 Lower risk of infections in ASCs than hospitals
3.2.2 Industry pitfalls and challenges
3.2.2.1 High costs of medical devices
3.2.2.2 Low physician-to-patient ratio
3.2.3 Market opportunities
3.2.3.1 Shift from inpatient to outpatient settings
3.2.3.2 Integration of AI and robotics in ASC surgeries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology and innovation landscape
3.5.1 Current technological trends
3.5.2 Emerging technologies
3.6 Ambulatory surgical centers - Shifting industry landscape
3.7 Historical timeline of ASCs
3.8 ASCs categorization, 2024
3.8.1 Operating room (OR)
3.8.2 Multi-specialty ASCs
3.8.3 ASC payer mix
3.9 ASCs procedure outlook - Most common and recent inclusions
3.10 Future market trends
3.11 Consumer behaviour analysis
3.12 Reimbursement scenario
3.13 Porter's analysis
3.14 PESTEL analysis
3.15 Gap analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
4.6.1 Mergers and acquisitions
4.6.2 Partnerships and collaborations
4.6.3 New product launches
4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Ownership, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Physician only
5.3 Hospital only
5.4 Corporate only
5.5 Physician and hospital
5.6 Physician and corporate
5.7 Other ownership types
Chapter 6 Market Estimates and Forecast, By Surgery Type, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Ophthalmology
6.3 Endoscopy
6.4 Orthopedic
6.5 Neurology
6.6 Pain management
6.7 Plastic Surgery
6.8 Podiatry
6.9 Otolaryngology
6.10 Obstetrics / Gynecology
6.11 Dental
6.12 Others surgery types
Chapter 7 Market Estimates and Forecast, By Specialty Type, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Single specialty
7.3 Multi specialty
Chapter 8 Market Estimates and Forecast, By Service, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 Treatment
8.3 Diagnosis
Chapter 9 Market Estimates and Forecast, By Zones, 2021 - 2034 ($ Mn)
9.1 Key trends
9.2 South Atlantic
9.2.1 Delaware
9.2.2 Florida
9.2.3 Georgia
9.2.4 Maryland
9.2.5 North Carolina
9.2.6 South Carolina
9.2.7 Virginia
9.2.8 West Virginia
9.2.9 Washington, D.C.
9.3 Pacific Central
9.3.1 Alaska
9.3.2 California
9.3.3 Hawaii
9.3.4 Oregon
9.3.5 Washington
9.4 Northeast
9.4.1 Connecticut
9.4.2 Maine
9.4.3 Massachusetts
9.4.4 New Hampshire
9.4.5 Rhode Island
9.4.6 Vermont
9.4.7 New Jersey
9.4.8 New York
9.4.9 Pennsylvania
9.5 East North Central
9.5.1 Illinois
9.5.2 Indiana
9.5.3 Michigan
9.5.4 Ohio
9.5.5 Wisconsin
9.6 West South Central
9.6.1 Arkansas
9.6.2 Louisiana
9.6.3 Oklahoma
9.6.4 Texas
9.7 West North Central
9.7.1 Iowa
9.7.2 Kansas
9.7.3 Minnesota
9.7.4 Missouri
9.7.5 Nebraska
9.7.6 North Dakota
9.7.7 South Dakota
9.8 East South Central
9.8.1 Alabama
9.8.2 Kentucky
9.8.3 Mississippi
9.8.4 Tennessee
9.9 Mountain States
9.9.1 Arizona
9.9.2 Colorado
9.9.3 Utah
9.9.4 Nevada
9.9.5 New Mexico
9.9.6 Idaho
9.9.7 Montana
9.9.8 Wyoming
Chapter 10 Company Profiles
10.1 AMBULATORY SURGICAL CENTER of AMERICA (ASCOA)
10.2 AMSURG
10.3 ASD MANAGEMENT
10.4 HCA Healthcare
10.5 Physicians endoscopy
10.6 Pinnacle III
10.7 Proliance SURGEONS
10.8 Regent Surgical
10.9 SCA HEALTH
10.10 SURGCENTER DEVELOPMENT
10.11 SURGERY PARTNERS
10.12 Surgical Management Professionals
10.13 Tenet Health
10.14 Trias MD
U.S. Ambulatory Surgical Centers Market Size
The U.S. ambulatory surgical centers market was estimated at USD 40 billion in 2024. The market is expected to grow from USD 42 billion in 2025 to USD 57.4 billion in 2034, at a CAGR of 3.5%. This high growth is attributed to several factors including rising prevalence of chronic diseases such as cancer, favorable reimbursements and government policies, increase in number of surgical procedures, and availability of treatments at comparatively lower rates than other healthcare facilities among other factors.
Ambulatory surgery centers (ASCs) serve as outpatient healthcare facilities where patients can receive surgical care, including diagnostic and preventive procedures. Major healthcare providers in the industry include Tenet Health, SCA HEALTH, and AMSURG, among other players. Physicians prefer to own these facilities, which represent the largest share in the ownership model segment, as it provides them with an additional source of income beyond professional fees, making these facilities a financially attractive option compared to other healthcare settings.
The market experienced strong growth, increasing from USD 33.2 billion in 2021 to USD 37.9 billion in 2023, with a CAGR of 3.5% over the analysis period. Several factors drove this growth, including more surgical procedures being performed, the expansion of ambulatory facilities across the country, and the availability of treatments at lower costs compared to hospital settings. The Leapfrog Group reports that outpatient facilities in the U.S. perform more than 60 million surgical procedures each year. This substantial number of procedures and the healthy growth rate suggest the market will continue its upward trend.
The rising number of chronic diseases such as cancer, heart disorders, and diabetes continues to be a leading cause of disability and deaths across the country. For instance, according to the statistics reported by Centers for Disease Control and Prevention (CDC), around 60% of Americans live with at least one chronic disease, while the other 40 percent manage two or more chronic conditions. As more patients seek early diagnosis and treatment for these conditions, the industry is positioned for continued growth.
Additionally, favorable reimbursements and government policies for ambulatory surgical centers continue to drive market growth. In 2023, the U.S. Department of Defense (DoD) made significant changes to TRICARE reimbursement policies for ambulatory surgery centers (ASCs) and outpatient services at Cancer and Children's Hospitals (CCHs). This change allows TRICARE to align with Medicare's payment system for both ASCs and outpatient services at CCHs, making healthcare more accessible to patients.
Ambulatory surgery centers (ASCs) serve as outpatient healthcare facilities where patients can receive surgical care, including diagnostic and preventive procedures. These facilities provide same day care for a range of surgical procedures.
U.S. Ambulatory Surgical Centers Market Trends
The market is expected to fuel the industry growth owing to trends including shift from inpatient to outpatient settings, integration of advanced equipment and solutions in the facility and expansion of ambulatory surgical center networks in the rural areas of country.
U.S. Ambulatory Surgical Centers Market Analysis
The U.S. ambulatory surgical centers market was valued at USD 33.2 billion in 2021. The market size reached USD 37.9 billion in 2023, from USD 35.6 billion in 2022.
Based on the ownership, the market is segmented into physician only, hospital only, corporate only, physician and hospital, physician and corporate, and other ownership types. The physician only segment accounted for 59.3% of the market in 2024 as the physician-led ambulatory settings have a comparatively better alignment of clinical and financial performance and have more control in the decision making. The segment is expected to exceed USD 32 billion by 2034, growing at a CAGR of 2.9% during the forecast period. Whereas the physician and hospital ownership category is expected to grow with the highest CAGR of 5% over the forecast timeline. This growth is attributed to growing dependency and involvement of physicians in a co-management role in this ownership model.
Based on the surgery type, the U.S. ambulatory surgical centers market is segmented into ophthalmology, endoscopy, orthopedic, neurology, pain management, plastic surgery, podiatry, otolaryngology, obstetrics/gynecology, dental, and others surgery types. The ophthalmology segment accounted for the highest market share of 25.8% in 2024 owing to high demand for various ophthalmic procedures such as cataract surgery, cost-effectiveness and growing aging population.
Based on specialty type, the U.S. ambulatory surgical centers market is segmented into single specialty and multi-specialty. The single specialty segment accounted for the highest market share of 59% in 2024 as these centers focus on specific surgical areas and are favored for their high reimbursement rates and strict safety standards.
Based on service, the U.S. ambulatory surgical centers market is segmented into treatment and diagnosis. The treatment segment accounted for the highest market share of 75.7% in 2024 owing to the rising incidence of chronic disorders, availability of cost-effective treatments with supportive reimbursement schemes.
South Atlantic zone dominated the U.S. ambulatory surgical centers market with the leading market share of 26.2% in 2024.
The Pacific Central zone ambulatory surgical centers market accounted for USD 8 billion in 2024.
U.S. Ambulatory Surgical Centers Market Share
Leading companies such as Tenet Health, SCA HEALTH, and AMSURG, together hold around 17% of the market share in the fragmented U.S. ambulatory surgical centers market. Major players are adopting key strategies, including joint ventures with physicians and health systems, integration of value-based care and technology, development of new ASCs, and specialty-focused expansion.
Major ASC operators, such as Tenet (through USPI) and SCA Health, are building joint ventures with physicians and hospitals to create better alignment between clinical and financial goals. When physicians and hospitals work together, it leads to more engaged doctors, better results for patients, and stronger networks for patient referrals. These partnerships help ASCs grow their presence in key markets while building integrated healthcare networks that bring in more patients, improve negotiations with insurance companies, and foster long-term collaboration.
Further, companies such as AMSURG and Regent Surgical Health are taking a focused approach by concentrating on specific medical specialties, particularly procedures that are both common and financially viable in areas like eye care, digestive health, and orthopedics. By specializing in this manner, these surgical centers can work more efficiently, complete procedures faster, and achieve better results for their patients.
Other industry operators such as HCA Healthcare, Regent Surgical and SURGERY PARTNERS have a substantial share of the market owing to the presence of ASCs across the country, better planning with physicians and adoption of advanced equipment in the facilities.
U.S. Ambulatory Surgical Centers Market Companies
Few of the prominent players operating in the U.S. ambulatory surgical centers industry include:
SCA Health builds its ambulatory surgery center (ASC) network by collaborating with physicians and health systems. The organization enhances clinical quality, streamline operations, and integrates digital solutions while adopting value-based care approaches to deliver better patient outcomes and satisfy payer needs across medical specialties.
Tenet Health, via USPI, focuses on aggressive ASC expansion through acquisitions and physician joint ventures. It emphasizes multi-specialty centers, integration with hospital systems, and value-based care models to strengthen its national footprint and drive outpatient surgical volume growth.
AMSURG concentrates on developing single-specialty ASCs, especially in gastroenterology and ophthalmology. It pursues joint ventures with physicians, emphasizes data-driven performance improvement, and expands its footprint through de novo facilities to maintain a leading position in the outpatient surgery market.
U.S. Ambulatory Surgical Centers Industry News:
The U.S. ambulatory surgical centers market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 - 2034 for the following segments:
Market, By Ownership
Market, By Surgery Type
Market, By Specialty Type
Market, By Service
The above information is provided for the following zones and states: